Product
NNC0487-0111
Aliases
NNC0487-0111 A
5 clinical trials
1 indication
Indication
ObesityClinical trial
Investigation of Safety, Tolerability and Pharmacokinetic Properties of Multiple Doses of Oral NNC0487-0111 in Japanese Participants With ObesityStatus: Completed, Estimated PCD: 2023-12-15
Clinical trial
A Randomised, Placebo-controlled and Double-blinded Study Assessing the Safety, Tolerability and Pharmacokinetics of Subcutaneous Administrations of NNC0487-0111 in Participants With Overweight or ObesityStatus: Recruiting, Estimated PCD: 2024-10-31
Clinical trial
Safety, Tolerability and Pharmacokinetics of NNC0487-0111 in Participants With Overweight or ObesityStatus: Completed, Estimated PCD: 2024-01-09
Clinical trial
Investigation of the Effect of NNC0487-0111 on Pharmacokinetics of an Oral Combination Contraceptive (Ethinylestradiol and Levonorgestrel) and Gastric Emptying in Females of Non-childbearing PotentialStatus: Not yet recruiting, Estimated PCD: 2025-03-17
Clinical trial
Investigating the Exposure of NNC0487-0111 in Different Oral Formulations and the Effect of Food Intake on Pharmacokinetics of NNC0487-0111 in Participants With Overweight or ObesityStatus: Not yet recruiting, Estimated PCD: 2024-12-30